Rosalind A. Segal

She is the recipient of a number of awards that recognize her teaching and research accomplishments including the Robert Ebert Clinical Scholar's Award from the Klingenstein Foundation, a McDonnell Foundation Award from the James S. McDonnell Foundation, the National Institutes of Health Director's Pioneer Award in 2006, and the Casty Family Award for Achievement in Mentoring. She was awarded a two-year $250,000 grant from Alex's Lemonade Stand Foundation in 2014. In 2017, she won the Harold Amos Faculty Diversity Award from Harvard Medical School.

Segal graduated with a Bachelor of Arts degree in 1979 jointly awarded by Harvard College and Radcliffe College. In 1986, she received both an MD from Weill Cornell Medicine and a PhD from Rockefeller University. She performed her doctoral dissertation research in the laboratory of David Luck, and her residency training in neurology in the Harvard affiliated hospitals in the Longwood Medical Area. Segal completed postdoctoral research in molecular neuroscience in the laboratories of Ronald McKay and Charles Stiles. In 1994, she started her own laboratory at Harvard Medical School's Beth Israel Deaconess Medical Center. She moved the laboratory to the site of the Dana–Farber Cancer Institute in 1998.

Rosalind Anne Segal (born 1958) is an American neurobiologist. She is a Professor of Neurobiology at Harvard Medical School and the Co-Chair of the Cancer Biology Department at the Dana Farber Cancer Institute. Segal's work employs modern methods of cell and molecular biology to study the development of the mammalian brain with the goal of understanding how disruption of this normal process leads to the formation of brain malignancies.